RxDoctor Payments Data

Jancy Civichan

Adult Health · Pleasantville, NJNPI 1952897829

Payments from drug & device makers

$716in general payments, 2019–2025

Across 45 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$237
  • UCB, Inc.$97
  • Sumitomo Pharma America, Inc.$63
  • SK Life Science, Inc.$56
  • Urovant Sciences Inc$40
  • Lilly USA, LLC$39
  • plus $184 from 10 others

What the payments were for

  • Food & beverage$716100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$716 in reported general payments places this provider in the 60th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$6,411
Medicare patients
31
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine13$94,479
ProliaDenosumab14$25,483
RexultiBrexpiprazole14$20,027
GemtesaVibegron36$18,157
VraylarCariprazine Hcl15$17,802
LinzessLinaclotide27$15,140
Lagevrio (Eua)Molnupiravir14$13,761
JanuviaSitagliptin Phosphate23$13,632
XcopriCenobamate11$12,316
Chlorpromazine Hcl52$11,418
Asenapine Maleate44$11,171
VascepaIcosapent Ethyl30$10,131
DepakoteDivalproex Sodium49$9,550
LamictalLamotrigine41$7,831
TradjentaLinagliptin12$6,533

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo, Albuterol Sulfate$237$95,57645 claims
AbbVieVraylar, Linzess$18$32,94242 claims
AmgenProlia$15$25,48314 claims
Otsuka America Pharmaceutical, Inc.Rexulti$19$20,02714 claims
Sumitomo Pharma America, Inc.Gemtesa$63$18,15736 claims
SK Life Science, Inc.Xcopri$56$12,31611 claims
Lilly USA, LLCOlanzapine$39$1,02169 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Pleasantville

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →